The United Patients Alliance Relaunches
The UPA medical cannabis patient group returns after a hiatus and will be meeting at the Brighton Medicinal Cannabis Summit 2023.
Reporting on drug policy, enforcement and the drugs trade. 663 pieces.
The UPA medical cannabis patient group returns after a hiatus and will be meeting at the Brighton Medicinal Cannabis Summit 2023.
Is falling asleep while taking magic mushrooms (aka psilocybin) a thing? Ruby Deevoy finds out and offers some harm reduction tips...
Germany's updated recreational cannabis legislation to be presented in the next few weeks...
From conspiracies, to cults, to political extremism, we dive into ways psychedelics have been historically used for nefarious purposes
Robert Veverka, editor-in-chief and sole publisher of Czech cannabis magazine Legalizace speaks about the court ruling and fine
UK charity Wellbeing of Women is looking into new treatments for endometriosis and its associated symptoms, including cannabis medicines.
Feeling not quite right the day after taking magic mushrooms? It could be a shrooms hangover. Ruby Deevoy writes on what it is and what to do.
The UK’s largest medical cannabis company Lyphe Group has announced a new capital raise and the completion of an internal restructure.
Drug Science and MedCan Support launch a digital study with company Alta Flora on treatment resistant childhood epilepsy and medical cannabis
Ruby Deevoy attends the the 'Psychedelics as Medicine' conference in Iceland.
Paul North and guest Alfredo Pascual discuss where Europe is at with regards to recreational cannabis reform.
What's next for the UK's CBD industry? We spoke to Robert Jappie about the sectors potential relationship with medical cannabis.
The Czech Republic has recently seen major reforms to its cannabis laws on medical cannabis, industrial hemp and recreational cannabis.
Paul North, Director of Volteface speaks to Arjun Rajyagor, CTO and Founder of Script Assist about how to improve cannabis prescribing.
On Volteface TV, Paul and Katya discuss why the UK politicians won't openly support UK drug policy reform and what can be done.
It’s been a busy start to the year for the UK cannabis industry. Here are the stories from the first month of 2023 that caught our eye.
In this article we examine if 2023 is going to be the year of psychedelic reform in the United Kingdom. Written by Megan Townsend
Is cannabis access leading some people to reduce their alcohol consumption? One study saw access to medical cannabis decrease alcohol sales.
What does the illegal cannabis start-up’s latest move mean for the medical market in the UK?
Here's 10 of our favourite Volteface pieces from the last 12 months to read over the festive period
It is becoming increasingly likely that Czechia may become the next European country to legalise recreational cannabis under new plans
On 16 November the MHRA published a blog post outlining the guidance for companies applying for approval for unlicensed cannabis-based medicines in the UK. In…
We all know the old adage, mushroom season comes but once a year, right?
Megan Townsend on the CROP17 initiative and attempts to alleviate some of the ongoing problems with medical cannabis access in the UK